Dr. Khalid Eljaaly, PharmD, MS, BCPS, BCIDP is an associate professor and infectious disease pharmacy consultant in the faculty of pharmacy at King Abdulaziz University (KAU) and Hospital, Jeddah, Saudi Arabia. He is the head of health interprofessional research branch in the university vice-presidency for development at KAU, and an honorary research fellow in college of pharmacy at University of Arizona, Tucson, AZ, USA. He completed an ASHP-accredited PGY2 infectious disease pharmacy residency at BIDMC, a Harvard Medical School-affiliated hospital in Boston, MA, USA. Then, he completed both infectious disease/antibiotic stewardship pharmacy fellowship and Master of Science in clinical translational sciences at University of Arizona. Khalid has several publications in high-ranked journals, and he co-authored a chapter in the British Society of Antimicrobial Chemotherapy (BSAC) electronic book for antibiotic stewardship. In addition, he co-authored the 2018 Saudi MOH Antimicrobial Therapy Guidelines for Community and Hospital Acquired Infections in Adults, as well as The Saudi Critical Care Society practice guidelines on the management of COVID-19 in the ICU. He received several international awards such as the IDWeek Trainee Award from IDSA, both Jonathan Freeman Scholarship and International Scholarship Award from SHEA, and Literature Award for Innovation in Pharmacy Practice from ASHP Foundation. Currently, he is an active member of the scientific program committee of ACCP global conference on clinical pharmacy. Khalid is a member of the editorial board of Contagion®, Saudi Journal of Clinical Pharmacy, which is owned by SSCP, and Antimicrobial Stewardship & Healthcare Epidemiology (ASHE), which is owned by SHEA.